nodes	percent_of_prediction	percent_of_DWPC	metapath
Abiraterone—CYP3A4—type 2 diabetes mellitus	0.135	0.534	CbGaD
Abiraterone—ALB—type 2 diabetes mellitus	0.118	0.466	CbGaD
Abiraterone—ORM1—Nateglinide—type 2 diabetes mellitus	0.0493	0.0971	CbGbCtD
Abiraterone—ALB—Gliclazide—type 2 diabetes mellitus	0.0322	0.0634	CbGbCtD
Abiraterone—ABCC1—Glyburide—type 2 diabetes mellitus	0.0304	0.0598	CbGbCtD
Abiraterone—ALB—Repaglinide—type 2 diabetes mellitus	0.0303	0.0596	CbGbCtD
Abiraterone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0292	0.0576	CbGbCtD
Abiraterone—ALB—Rosiglitazone—type 2 diabetes mellitus	0.0252	0.0497	CbGbCtD
Abiraterone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0234	0.046	CbGbCtD
Abiraterone—ALB—Valsartan—type 2 diabetes mellitus	0.0223	0.0439	CbGbCtD
Abiraterone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0211	0.0416	CbGbCtD
Abiraterone—ALB—Nateglinide—type 2 diabetes mellitus	0.0207	0.0408	CbGbCtD
Abiraterone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0195	0.0384	CbGbCtD
Abiraterone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0188	0.0371	CbGbCtD
Abiraterone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0154	0.0303	CbGbCtD
Abiraterone—ALB—Glyburide—type 2 diabetes mellitus	0.014	0.0276	CbGbCtD
Abiraterone—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0135	0.0266	CbGbCtD
Abiraterone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0133	0.0262	CbGbCtD
Abiraterone—ALB—Losartan—type 2 diabetes mellitus	0.0128	0.0252	CbGbCtD
Abiraterone—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0124	0.0245	CbGbCtD
Abiraterone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0119	0.0234	CbGbCtD
Abiraterone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0108	0.0214	CbGbCtD
Abiraterone—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0102	0.0201	CbGbCtD
Abiraterone—CYP2C8—Losartan—type 2 diabetes mellitus	0.0099	0.0195	CbGbCtD
Abiraterone—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0098	0.0193	CbGbCtD
Abiraterone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00948	0.0187	CbGbCtD
Abiraterone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00857	0.0169	CbGbCtD
Abiraterone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0065	0.0128	CbGbCtD
Abiraterone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00623	0.0123	CbGbCtD
Abiraterone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00623	0.0123	CbGbCtD
Abiraterone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00589	0.0116	CbGbCtD
Abiraterone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00439	0.00864	CbGbCtD
Abiraterone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00401	0.00791	CbGbCtD
Abiraterone—Testosterone—CYP11A1—type 2 diabetes mellitus	0.000663	0.36	CrCbGaD
Abiraterone—Testosterone—SHBG—type 2 diabetes mellitus	0.000467	0.254	CrCbGaD
Abiraterone—Testosterone—AR—type 2 diabetes mellitus	0.00041	0.222	CrCbGaD
Abiraterone—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000235	0.00173	CcSEcCtD
Abiraterone—Anaemia—Glyburide—type 2 diabetes mellitus	0.000235	0.00173	CcSEcCtD
Abiraterone—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000234	0.00172	CcSEcCtD
Abiraterone—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000234	0.00172	CcSEcCtD
Abiraterone—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000233	0.00172	CcSEcCtD
Abiraterone—Hyperglycaemia—Irbesartan—type 2 diabetes mellitus	0.000233	0.00172	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Glipizide—type 2 diabetes mellitus	0.000233	0.00171	CcSEcCtD
Abiraterone—Pneumonia—Irbesartan—type 2 diabetes mellitus	0.000232	0.00171	CcSEcCtD
Abiraterone—Constipation—Glipizide—type 2 diabetes mellitus	0.000231	0.0017	CcSEcCtD
Abiraterone—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00023	0.00169	CcSEcCtD
Abiraterone—Mental disorder—Gliclazide—type 2 diabetes mellitus	0.00023	0.00169	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00168	CcSEcCtD
Abiraterone—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000228	0.00167	CcSEcCtD
Abiraterone—Acute coronary syndrome—Irbesartan—type 2 diabetes mellitus	0.000227	0.00167	CcSEcCtD
Abiraterone—Oedema—Bromocriptine—type 2 diabetes mellitus	0.000227	0.00167	CcSEcCtD
Abiraterone—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000227	0.00167	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000226	0.00166	CcSEcCtD
Abiraterone—Myocardial infarction—Irbesartan—type 2 diabetes mellitus	0.000226	0.00166	CcSEcCtD
Abiraterone—Infection—Bromocriptine—type 2 diabetes mellitus	0.000226	0.00166	CcSEcCtD
Abiraterone—Pollakiuria—Losartan—type 2 diabetes mellitus	0.000225	0.00165	CcSEcCtD
Abiraterone—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000224	0.00165	CcSEcCtD
Abiraterone—Urinary tract infection—Irbesartan—type 2 diabetes mellitus	0.000224	0.00165	CcSEcCtD
Abiraterone—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000224	0.00165	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00164	CcSEcCtD
Abiraterone—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000223	0.00164	CcSEcCtD
Abiraterone—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000223	0.00164	CcSEcCtD
Abiraterone—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000222	0.00163	CcSEcCtD
Abiraterone—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000221	0.00163	CcSEcCtD
Abiraterone—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000221	0.00162	CcSEcCtD
Abiraterone—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00162	CcSEcCtD
Abiraterone—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.00022	0.00162	CcSEcCtD
Abiraterone—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000219	0.00161	CcSEcCtD
Abiraterone—Pneumonia—Losartan—type 2 diabetes mellitus	0.000218	0.00161	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000217	0.0016	CcSEcCtD
Abiraterone—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000217	0.0016	CcSEcCtD
Abiraterone—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000217	0.0016	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00159	CcSEcCtD
Abiraterone—Myalgia—Glyburide—type 2 diabetes mellitus	0.000217	0.00159	CcSEcCtD
Abiraterone—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000216	0.00159	CcSEcCtD
Abiraterone—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000216	0.00159	CcSEcCtD
Abiraterone—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000215	0.00158	CcSEcCtD
Abiraterone—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000215	0.00158	CcSEcCtD
Abiraterone—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000211	0.00155	CcSEcCtD
Abiraterone—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000211	0.00155	CcSEcCtD
Abiraterone—Urinary tract infection—Losartan—type 2 diabetes mellitus	0.000211	0.00155	CcSEcCtD
Abiraterone—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000211	0.00155	CcSEcCtD
Abiraterone—Mental disorder—Orlistat—type 2 diabetes mellitus	0.000209	0.00153	CcSEcCtD
Abiraterone—Oedema—Glyburide—type 2 diabetes mellitus	0.000208	0.00153	CcSEcCtD
Abiraterone—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000207	0.00152	CcSEcCtD
Abiraterone—Rash—Repaglinide—type 2 diabetes mellitus	0.000206	0.00151	CcSEcCtD
Abiraterone—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00151	CcSEcCtD
Abiraterone—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000205	0.00151	CcSEcCtD
Abiraterone—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000205	0.0015	CcSEcCtD
Abiraterone—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000204	0.0015	CcSEcCtD
Abiraterone—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000204	0.0015	CcSEcCtD
Abiraterone—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000203	0.00149	CcSEcCtD
Abiraterone—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000202	0.00149	CcSEcCtD
Abiraterone—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.0002	0.00147	CcSEcCtD
Abiraterone—Cough—Gliclazide—type 2 diabetes mellitus	0.000199	0.00147	CcSEcCtD
Abiraterone—Angiopathy—Metformin—type 2 diabetes mellitus	0.000199	0.00146	CcSEcCtD
Abiraterone—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000198	0.00145	CcSEcCtD
Abiraterone—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000197	0.00145	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00144	CcSEcCtD
Abiraterone—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000196	0.00144	CcSEcCtD
Abiraterone—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000194	0.00143	CcSEcCtD
Abiraterone—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000194	0.00143	CcSEcCtD
Abiraterone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000194	0.00143	CcSEcCtD
Abiraterone—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000194	0.00143	CcSEcCtD
Abiraterone—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000194	0.00143	CcSEcCtD
Abiraterone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000194	0.00143	CcSEcCtD
Abiraterone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000194	0.00142	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000193	0.00142	CcSEcCtD
Abiraterone—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.00141	CcSEcCtD
Abiraterone—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000192	0.00141	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000189	0.00139	CcSEcCtD
Abiraterone—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000188	0.00138	CcSEcCtD
Abiraterone—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000187	0.00137	CcSEcCtD
Abiraterone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Abiraterone—Infection—Gliclazide—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Abiraterone—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Abiraterone—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Abiraterone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000185	0.00136	CcSEcCtD
Abiraterone—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000184	0.00135	CcSEcCtD
Abiraterone—Cough—Valsartan—type 2 diabetes mellitus	0.000183	0.00135	CcSEcCtD
Abiraterone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000183	0.00134	CcSEcCtD
Abiraterone—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000183	0.00134	CcSEcCtD
Abiraterone—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000181	0.00133	CcSEcCtD
Abiraterone—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000181	0.00133	CcSEcCtD
Abiraterone—Cough—Orlistat—type 2 diabetes mellitus	0.000181	0.00133	CcSEcCtD
Abiraterone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000181	0.00133	CcSEcCtD
Abiraterone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00132	CcSEcCtD
Abiraterone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00132	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000179	0.00132	CcSEcCtD
Abiraterone—Chest pain—Valsartan—type 2 diabetes mellitus	0.000179	0.00131	CcSEcCtD
Abiraterone—Myalgia—Valsartan—type 2 diabetes mellitus	0.000179	0.00131	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Abiraterone—Angiopathy—Losartan—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Abiraterone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Abiraterone—Myalgia—Orlistat—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Abiraterone—Chest pain—Orlistat—type 2 diabetes mellitus	0.000177	0.0013	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000175	0.00129	CcSEcCtD
Abiraterone—Discomfort—Orlistat—type 2 diabetes mellitus	0.000174	0.00128	CcSEcCtD
Abiraterone—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000174	0.00128	CcSEcCtD
Abiraterone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000172	0.00127	CcSEcCtD
Abiraterone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000172	0.00126	CcSEcCtD
Abiraterone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000171	0.00126	CcSEcCtD
Abiraterone—Oedema—Valsartan—type 2 diabetes mellitus	0.000171	0.00126	CcSEcCtD
Abiraterone—Infection—Valsartan—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Abiraterone—Rash—Glipizide—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Abiraterone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00017	0.00125	CcSEcCtD
Abiraterone—Oedema—Orlistat—type 2 diabetes mellitus	0.000169	0.00124	CcSEcCtD
Abiraterone—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000169	0.00124	CcSEcCtD
Abiraterone—Infection—Orlistat—type 2 diabetes mellitus	0.000168	0.00124	CcSEcCtD
Abiraterone—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000167	0.00123	CcSEcCtD
Abiraterone—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000166	0.00122	CcSEcCtD
Abiraterone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000166	0.00122	CcSEcCtD
Abiraterone—Hypertension—Metformin—type 2 diabetes mellitus	0.000165	0.00121	CcSEcCtD
Abiraterone—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000164	0.00121	CcSEcCtD
Abiraterone—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000164	0.00121	CcSEcCtD
Abiraterone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000164	0.00121	CcSEcCtD
Abiraterone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000163	0.0012	CcSEcCtD
Abiraterone—Chest pain—Metformin—type 2 diabetes mellitus	0.000163	0.0012	CcSEcCtD
Abiraterone—Myalgia—Metformin—type 2 diabetes mellitus	0.000163	0.0012	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000162	0.00119	CcSEcCtD
Abiraterone—Testosterone—CYP3A4—type 2 diabetes mellitus	0.000161	0.0875	CrCbGaD
Abiraterone—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Abiraterone—Discomfort—Metformin—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Abiraterone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000161	0.00118	CcSEcCtD
Abiraterone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00016	0.00118	CcSEcCtD
Abiraterone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00016	0.00117	CcSEcCtD
Abiraterone—Constipation—Gliclazide—type 2 diabetes mellitus	0.000159	0.00117	CcSEcCtD
Abiraterone—Rash—Glimepiride—type 2 diabetes mellitus	0.000159	0.00117	CcSEcCtD
Abiraterone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000159	0.00117	CcSEcCtD
Abiraterone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00116	CcSEcCtD
Abiraterone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000158	0.00116	CcSEcCtD
Abiraterone—Cough—Irbesartan—type 2 diabetes mellitus	0.000157	0.00116	CcSEcCtD
Abiraterone—Anaemia—Losartan—type 2 diabetes mellitus	0.000157	0.00115	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000156	0.00115	CcSEcCtD
Abiraterone—Oedema—Metformin—type 2 diabetes mellitus	0.000156	0.00115	CcSEcCtD
Abiraterone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000156	0.00114	CcSEcCtD
Abiraterone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00114	CcSEcCtD
Abiraterone—Infection—Metformin—type 2 diabetes mellitus	0.000155	0.00114	CcSEcCtD
Abiraterone—Insomnia—Valsartan—type 2 diabetes mellitus	0.000155	0.00114	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000154	0.00113	CcSEcCtD
Abiraterone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000154	0.00113	CcSEcCtD
Abiraterone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000154	0.00113	CcSEcCtD
Abiraterone—Insomnia—Orlistat—type 2 diabetes mellitus	0.000153	0.00113	CcSEcCtD
Abiraterone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000153	0.00112	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000152	0.00112	CcSEcCtD
Abiraterone—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000152	0.00112	CcSEcCtD
Abiraterone—Skin disorder—Metformin—type 2 diabetes mellitus	0.000151	0.00111	CcSEcCtD
Abiraterone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000151	0.00111	CcSEcCtD
Abiraterone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000151	0.00111	CcSEcCtD
Abiraterone—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Abiraterone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Abiraterone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000149	0.0011	CcSEcCtD
Abiraterone—Cough—Losartan—type 2 diabetes mellitus	0.000148	0.00109	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000148	0.00109	CcSEcCtD
Abiraterone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000148	0.00109	CcSEcCtD
Abiraterone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000147	0.00108	CcSEcCtD
Abiraterone—Oedema—Irbesartan—type 2 diabetes mellitus	0.000147	0.00108	CcSEcCtD
Abiraterone—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000146	0.00108	CcSEcCtD
Abiraterone—Constipation—Valsartan—type 2 diabetes mellitus	0.000146	0.00108	CcSEcCtD
Abiraterone—Infection—Irbesartan—type 2 diabetes mellitus	0.000146	0.00108	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Abiraterone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000146	0.00107	CcSEcCtD
Abiraterone—Chest pain—Losartan—type 2 diabetes mellitus	0.000144	0.00106	CcSEcCtD
Abiraterone—Myalgia—Losartan—type 2 diabetes mellitus	0.000144	0.00106	CcSEcCtD
Abiraterone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000144	0.00106	CcSEcCtD
Abiraterone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Abiraterone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Abiraterone—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Abiraterone—Discomfort—Losartan—type 2 diabetes mellitus	0.000143	0.00105	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000142	0.00104	CcSEcCtD
Abiraterone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000142	0.00104	CcSEcCtD
Abiraterone—Testosterone—ALB—type 2 diabetes mellitus	0.00014	0.0763	CrCbGaD
Abiraterone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Abiraterone—Oedema—Losartan—type 2 diabetes mellitus	0.000139	0.00102	CcSEcCtD
Abiraterone—Infection—Losartan—type 2 diabetes mellitus	0.000138	0.00101	CcSEcCtD
Abiraterone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000137	0.00101	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000135	0.00099	CcSEcCtD
Abiraterone—Fatigue—Metformin—type 2 diabetes mellitus	0.000134	0.000989	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000134	0.000986	CcSEcCtD
Abiraterone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000134	0.000984	CcSEcCtD
Abiraterone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000134	0.000983	CcSEcCtD
Abiraterone—Constipation—Metformin—type 2 diabetes mellitus	0.000133	0.000981	CcSEcCtD
Abiraterone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000132	0.000971	CcSEcCtD
Abiraterone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000131	0.000965	CcSEcCtD
Abiraterone—Rash—Glyburide—type 2 diabetes mellitus	0.000131	0.000962	CcSEcCtD
Abiraterone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000131	0.000962	CcSEcCtD
Abiraterone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00013	0.000953	CcSEcCtD
Abiraterone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000128	0.000938	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000127	0.000934	CcSEcCtD
Abiraterone—Cough—Ramipril—type 2 diabetes mellitus	0.000127	0.000934	CcSEcCtD
Abiraterone—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000127	0.000933	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000126	0.000928	CcSEcCtD
Abiraterone—Constipation—Irbesartan—type 2 diabetes mellitus	0.000126	0.000925	CcSEcCtD
Abiraterone—Insomnia—Losartan—type 2 diabetes mellitus	0.000125	0.000921	CcSEcCtD
Abiraterone—Chest pain—Ramipril—type 2 diabetes mellitus	0.000124	0.000911	CcSEcCtD
Abiraterone—Myalgia—Ramipril—type 2 diabetes mellitus	0.000124	0.000911	CcSEcCtD
Abiraterone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000123	0.000908	CcSEcCtD
Abiraterone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000123	0.000905	CcSEcCtD
Abiraterone—Asthenia—Valsartan—type 2 diabetes mellitus	0.000123	0.000904	CcSEcCtD
Abiraterone—Discomfort—Ramipril—type 2 diabetes mellitus	0.000122	0.0009	CcSEcCtD
Abiraterone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000122	0.000897	CcSEcCtD
Abiraterone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000121	0.000893	CcSEcCtD
Abiraterone—Fatigue—Losartan—type 2 diabetes mellitus	0.000119	0.000878	CcSEcCtD
Abiraterone—Oedema—Ramipril—type 2 diabetes mellitus	0.000119	0.000873	CcSEcCtD
Abiraterone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000119	0.000871	CcSEcCtD
Abiraterone—Constipation—Losartan—type 2 diabetes mellitus	0.000118	0.000871	CcSEcCtD
Abiraterone—Rash—Gliclazide—type 2 diabetes mellitus	0.000118	0.000864	CcSEcCtD
Abiraterone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000117	0.000863	CcSEcCtD
Abiraterone—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000117	0.000862	CcSEcCtD
Abiraterone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000116	0.000856	CcSEcCtD
Abiraterone—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000116	0.000851	CcSEcCtD
Abiraterone—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000115	0.000848	CcSEcCtD
Abiraterone—Asthenia—Metformin—type 2 diabetes mellitus	0.000112	0.000823	CcSEcCtD
Abiraterone—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000109	0.000805	CcSEcCtD
Abiraterone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000109	0.000801	CcSEcCtD
Abiraterone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000108	0.000796	CcSEcCtD
Abiraterone—Rash—Valsartan—type 2 diabetes mellitus	0.000108	0.000794	CcSEcCtD
Abiraterone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000108	0.000793	CcSEcCtD
Abiraterone—Vomiting—Orlistat—type 2 diabetes mellitus	0.000108	0.000791	CcSEcCtD
Abiraterone—Insomnia—Ramipril—type 2 diabetes mellitus	0.000107	0.00079	CcSEcCtD
Abiraterone—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000107	0.000785	CcSEcCtD
Abiraterone—Rash—Orlistat—type 2 diabetes mellitus	0.000107	0.000785	CcSEcCtD
Abiraterone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000107	0.000784	CcSEcCtD
Abiraterone—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000106	0.000779	CcSEcCtD
Abiraterone—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000106	0.000776	CcSEcCtD
Abiraterone—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000105	0.000769	CcSEcCtD
Abiraterone—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000103	0.000754	CcSEcCtD
Abiraterone—Fatigue—Ramipril—type 2 diabetes mellitus	0.000102	0.000753	CcSEcCtD
Abiraterone—Constipation—Ramipril—type 2 diabetes mellitus	0.000102	0.000747	CcSEcCtD
Abiraterone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000101	0.00074	CcSEcCtD
Abiraterone—Asthenia—Losartan—type 2 diabetes mellitus	9.94e-05	0.000731	CcSEcCtD
Abiraterone—Vomiting—Metformin—type 2 diabetes mellitus	9.92e-05	0.000729	CcSEcCtD
Abiraterone—Rash—Metformin—type 2 diabetes mellitus	9.83e-05	0.000723	CcSEcCtD
Abiraterone—Dermatitis—Metformin—type 2 diabetes mellitus	9.82e-05	0.000722	CcSEcCtD
Abiraterone—Diarrhoea—Losartan—type 2 diabetes mellitus	9.48e-05	0.000697	CcSEcCtD
Abiraterone—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.39e-05	0.00069	CcSEcCtD
Abiraterone—Vomiting—Irbesartan—type 2 diabetes mellitus	9.36e-05	0.000688	CcSEcCtD
Abiraterone—Rash—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000682	CcSEcCtD
Abiraterone—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.27e-05	0.000682	CcSEcCtD
Abiraterone—Vomiting—Losartan—type 2 diabetes mellitus	8.81e-05	0.000648	CcSEcCtD
Abiraterone—Rash—Losartan—type 2 diabetes mellitus	8.73e-05	0.000642	CcSEcCtD
Abiraterone—Dermatitis—Losartan—type 2 diabetes mellitus	8.72e-05	0.000642	CcSEcCtD
Abiraterone—Asthenia—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000627	CcSEcCtD
Abiraterone—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.13e-05	0.000598	CcSEcCtD
Abiraterone—Vomiting—Ramipril—type 2 diabetes mellitus	7.55e-05	0.000555	CcSEcCtD
Abiraterone—Rash—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000551	CcSEcCtD
Abiraterone—Dermatitis—Ramipril—type 2 diabetes mellitus	7.48e-05	0.00055	CcSEcCtD
Abiraterone—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	6.57e-06	6.51e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	6.57e-06	6.51e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	6.57e-06	6.51e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	6.52e-06	6.46e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	6.52e-06	6.46e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CPT1A—type 2 diabetes mellitus	6.48e-06	6.42e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTR—type 2 diabetes mellitus	6.48e-06	6.42e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	6.45e-06	6.39e-05	CbGpPWpGaD
Abiraterone—SULT2A1—Metabolism—AKT1—type 2 diabetes mellitus	6.4e-06	6.34e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	6.39e-06	6.34e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—MTHFR—type 2 diabetes mellitus	6.39e-06	6.33e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NAMPT—type 2 diabetes mellitus	6.36e-06	6.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.36e-06	6.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	6.35e-06	6.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	6.35e-06	6.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	6.35e-06	6.3e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IRS1—type 2 diabetes mellitus	6.34e-06	6.28e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.32e-06	6.26e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LIPC—type 2 diabetes mellitus	6.32e-06	6.26e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HBA1—type 2 diabetes mellitus	6.32e-06	6.26e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GCK—type 2 diabetes mellitus	6.32e-06	6.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	6.32e-06	6.26e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	6.3e-06	6.24e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP11A1—type 2 diabetes mellitus	6.28e-06	6.22e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARA—type 2 diabetes mellitus	6.27e-06	6.21e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SERPINE1—type 2 diabetes mellitus	6.26e-06	6.2e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	6.2e-06	6.14e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC9A1—type 2 diabetes mellitus	6.17e-06	6.11e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	6.13e-06	6.07e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CETP—type 2 diabetes mellitus	6.1e-06	6.04e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.09e-06	6.04e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.09e-06	6.04e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AGT—type 2 diabetes mellitus	6.08e-06	6.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—INS—type 2 diabetes mellitus	6.07e-06	6.02e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—CALM1—type 2 diabetes mellitus	5.97e-06	5.92e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—PIK3R1—type 2 diabetes mellitus	5.97e-06	5.92e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—NOS3—type 2 diabetes mellitus	5.97e-06	5.92e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOE—type 2 diabetes mellitus	5.95e-06	5.9e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.94e-06	5.88e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—APOA1—type 2 diabetes mellitus	5.88e-06	5.83e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT2—type 2 diabetes mellitus	5.87e-06	5.81e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	5.85e-06	5.8e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.72e-06	5.66e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	5.7e-06	5.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	5.7e-06	5.65e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	5.7e-06	5.65e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SREBF1—type 2 diabetes mellitus	5.67e-06	5.61e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SNAP25—type 2 diabetes mellitus	5.67e-06	5.61e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PSMD6—type 2 diabetes mellitus	5.67e-06	5.61e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.67e-06	5.61e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.67e-06	5.61e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.67e-06	5.61e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	5.59e-06	5.54e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SERPINE1—type 2 diabetes mellitus	5.58e-06	5.53e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CTGF—type 2 diabetes mellitus	5.56e-06	5.51e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	5.54e-06	5.49e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMGCR—type 2 diabetes mellitus	5.51e-06	5.46e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.47e-06	5.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.46e-06	5.41e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.44e-06	5.39e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.43e-06	5.38e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.43e-06	5.38e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	5.43e-06	5.38e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADRA2A—type 2 diabetes mellitus	5.4e-06	5.35e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.35e-06	5.3e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.35e-06	5.3e-05	CbGpPWpGaD
Abiraterone—ALB—Platelet activation, signaling and aggregation—AKT1—type 2 diabetes mellitus	5.33e-06	5.28e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—NOS3—type 2 diabetes mellitus	5.32e-06	5.28e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PIK3R1—type 2 diabetes mellitus	5.32e-06	5.28e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	5.25e-06	5.2e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.23e-06	5.18e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.23e-06	5.18e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	5.22e-06	5.17e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	5.22e-06	5.17e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	5.22e-06	5.17e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	5.21e-06	5.16e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PPARG—type 2 diabetes mellitus	5.18e-06	5.14e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	5.18e-06	5.14e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP2E1—type 2 diabetes mellitus	5.18e-06	5.14e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.15e-06	5.11e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.15e-06	5.11e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.14e-06	5.09e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP1A2—type 2 diabetes mellitus	5.13e-06	5.08e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A1—type 2 diabetes mellitus	5.13e-06	5.08e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	5.09e-06	5.04e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—INS—type 2 diabetes mellitus	5.09e-06	5.04e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.05e-06	5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.05e-06	5e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.05e-06	5e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	5.03e-06	4.99e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	5.03e-06	4.98e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5e-06	4.95e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CYP3A4—type 2 diabetes mellitus	5e-06	4.95e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.97e-06	4.93e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	4.94e-06	4.9e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	4.94e-06	4.9e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GCG—type 2 diabetes mellitus	4.91e-06	4.87e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—SLC2A4—type 2 diabetes mellitus	4.91e-06	4.87e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—PTGS2—type 2 diabetes mellitus	4.87e-06	4.83e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.75e-06	4.7e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.68e-06	4.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.68e-06	4.64e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.68e-06	4.64e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—ALB—type 2 diabetes mellitus	4.66e-06	4.62e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.59e-06	4.55e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.55e-06	4.51e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—NOS3—type 2 diabetes mellitus	4.46e-06	4.42e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.46e-06	4.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.45e-06	4.41e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.45e-06	4.4e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—SRC—type 2 diabetes mellitus	4.42e-06	4.38e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—VEGFA—type 2 diabetes mellitus	4.3e-06	4.26e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.29e-06	4.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.29e-06	4.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.29e-06	4.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.29e-06	4.25e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.28e-06	4.24e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.26e-06	4.22e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.26e-06	4.22e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.24e-06	4.2e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.24e-06	4.2e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GNB3—type 2 diabetes mellitus	4.24e-06	4.2e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.23e-06	4.19e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.23e-06	4.19e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—HMOX1—type 2 diabetes mellitus	4.22e-06	4.18e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.18e-06	4.14e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CAT—type 2 diabetes mellitus	4.16e-06	4.12e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	4.13e-06	4.09e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.12e-06	4.08e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—PTGS2—type 2 diabetes mellitus	4.08e-06	4.04e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.06e-06	4.02e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	4.06e-06	4.02e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	4.06e-06	4.02e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOB—type 2 diabetes mellitus	4.04e-06	4e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.95e-06	3.91e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—TGFB1—type 2 diabetes mellitus	3.95e-06	3.91e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—SRC—type 2 diabetes mellitus	3.94e-06	3.9e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GSTM1—type 2 diabetes mellitus	3.93e-06	3.89e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.88e-06	3.84e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—LPL—type 2 diabetes mellitus	3.86e-06	3.82e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.83e-06	3.79e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.8e-06	3.76e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.78e-06	3.75e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—ADCY5—type 2 diabetes mellitus	3.77e-06	3.74e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—GPX1—type 2 diabetes mellitus	3.76e-06	3.73e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.68e-06	3.65e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CD36—type 2 diabetes mellitus	3.66e-06	3.63e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.64e-06	3.6e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPP2CA—type 2 diabetes mellitus	3.62e-06	3.58e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.57e-06	3.54e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—TGFB1—type 2 diabetes mellitus	3.52e-06	3.49e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.5e-06	3.47e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.5e-06	3.47e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.5e-06	3.46e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.5e-06	3.46e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.49e-06	3.46e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.48e-06	3.45e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—MTHFR—type 2 diabetes mellitus	3.47e-06	3.44e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—EGFR—type 2 diabetes mellitus	3.45e-06	3.42e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.43e-06	3.4e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.43e-06	3.4e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.43e-06	3.39e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.41e-06	3.38e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.41e-06	3.38e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.41e-06	3.38e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARA—type 2 diabetes mellitus	3.41e-06	3.37e-05	CbGpPWpGaD
Abiraterone—CYP17A1—Metabolism—AKT1—type 2 diabetes mellitus	3.4e-06	3.37e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.39e-06	3.36e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.33e-06	3.3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.33e-06	3.3e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.32e-06	3.29e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AGT—type 2 diabetes mellitus	3.3e-06	3.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.29e-06	3.26e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.26e-06	3.23e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.25e-06	3.22e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—CALM1—type 2 diabetes mellitus	3.24e-06	3.21e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.24e-06	3.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOE—type 2 diabetes mellitus	3.23e-06	3.2e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.21e-06	3.18e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—APOA1—type 2 diabetes mellitus	3.2e-06	3.17e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.18e-06	3.15e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.12e-06	3.09e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.11e-06	3.08e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.06e-06	3.03e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.06e-06	3.03e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.06e-06	3.03e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.02e-06	3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3e-06	2.98e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.99e-06	2.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.98e-06	2.95e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.91e-06	2.89e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.87e-06	2.84e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.83e-06	2.81e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PPARG—type 2 diabetes mellitus	2.82e-06	2.79e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.81e-06	2.79e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.8e-06	2.77e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.78e-06	2.75e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.77e-06	2.74e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.77e-06	2.74e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—INS—type 2 diabetes mellitus	2.76e-06	2.74e-05	CbGpPWpGaD
Abiraterone—ALB—Hemostasis—AKT1—type 2 diabetes mellitus	2.75e-06	2.72e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.72e-06	2.7e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.68e-06	2.65e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.67e-06	2.64e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—IL6—type 2 diabetes mellitus	2.65e-06	2.63e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.65e-06	2.63e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.65e-06	2.63e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.64e-06	2.61e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.55e-06	2.52e-05	CbGpPWpGaD
Abiraterone—ABCC1—Disease—AKT1—type 2 diabetes mellitus	2.45e-06	2.43e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.44e-06	2.41e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.44e-06	2.41e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PIK3R1—type 2 diabetes mellitus	2.42e-06	2.4e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—NOS3—type 2 diabetes mellitus	2.42e-06	2.4e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.32e-06	2.3e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.29e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.29e-06	2.27e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.28e-06	2.26e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.28e-06	2.25e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.25e-06	2.22e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.23e-06	2.21e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—PTGS2—type 2 diabetes mellitus	2.21e-06	2.19e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.18e-06	2.16e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.12e-06	2.1e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.09e-06	2.07e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.08e-06	2.06e-05	CbGpPWpGaD
Abiraterone—ABCC1—Metabolism—AKT1—type 2 diabetes mellitus	2.05e-06	2.03e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.04e-06	2.02e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.03e-06	2.01e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2e-06	1.98e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2e-06	1.98e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.98e-06	1.96e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.95e-06	1.93e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.87e-06	1.86e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.84e-06	1.82e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.83e-06	1.81e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.78e-06	1.76e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.75e-06	1.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.74e-06	1.73e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.72e-06	1.71e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.52e-06	1.51e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.49e-06	1.48e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.37e-06	1.35e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.31e-06	1.29e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.31e-06	1.29e-05	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.2e-06	1.18e-05	CbGpPWpGaD
Abiraterone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.12e-06	1.11e-05	CbGpPWpGaD
Abiraterone—ALB—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	1.1e-05	CbGpPWpGaD
Abiraterone—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	9.19e-07	9.1e-06	CbGpPWpGaD
Abiraterone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.01e-07	5.95e-06	CbGpPWpGaD
